CRDF Sues NMS Over Patent Inventorship, Seeks Injunction; NMS Terminates $150M Agreement
Cardiff Oncology, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $1.90
+1.1% in 1h after detection
Post-detection moves
1h
+1.1%
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS